Navigation Links
Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia

Recent research conducted in Germany indicates that bronchiolo–alveolar carcinoma frequently shows a sonographic pattern of ‘pneumonia’//.

The acoustic–physical conditions of the thorax produces the most serious limitations for the sonographic diagnosis of pulmonary diseases.

Sonography of pleural-based lesions has been established as a method complementary to conventional X-ray examination. The sonographic pattern of bacterial pneumonia is predominantly well known and characterized by an air bronchogram, a marked vascularity on color Doppler sonography, and a high-impedance arterial flow pattern on Doppler spectral analysis.

Bronchiolo–alveolar carcinoma (BAC) is defined as a special subtype of adenocarcinoma. Histologically it shows wallpaper like growth within the alveoli, confirmed to the topographical structures of the lung tissue.

The authors set out to describe the sonographic patterns of this tumor entity in seven consecutive patients with peripheral BAC on X-ray examination. Their findings appear in the October issue of the European Journal of Ultrasound. The analysis of data from this study demonstrates a marked vascularity or a vascular tree like pattern in all patients with BAC investigated, which are known to be characteristic for pneumonic or obstructive pulmonary lesions. The arterial spectral analysis of the patients predominantly showed a high-impedance flow in nearly all cases investigated. This flow pattern is also described to be characteristic for pneumonic or obstructive pulmonary lesions and is a well-known flow pattern of pulmonary arteries.

The authors conclude that BAC predominantly shows a pattern of ‘pneumonia’ as demonstrated by conventional B-mode sonography as well as color Doppler sonogrphy.

Page: 1

Related medicine news :

1. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
2. Differentiated Thyroid Carcinoma Can Widely Infiltrate The Larynx
3. Probable Biomarkers for Squamous Cell Carcinoma
4. New Biotech Drugs to Aid in Renal Cell Carcinoma Treatment
5. Experimental treatment for Ebola Virus Shows promising results in mice
6. New Prostate Cancer Vaccine Shows Promise
7. Ebola Treatment Shows Promise
8. New Drug Shows Significant Improvement In HIV-related Heart Condition
9. Greek Study Shows Living In The Hills May Be Healthier
10. Research Shows Carbon Monoxide Prevents Inflammations
11. Latest Research Shows That Multivitamins Might Not Prevent Infections In All Elderly
Post Your Comments:

(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from reveals that behind the tendency to set low ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: